Taq DNA Polymerase
Key Feature
- Terminal Transferase Activity: Taq DNA Polymerase has terminal transferase activity which results in the addition of a single nucleotide (adenosine) at the 3' end of the extension product.
- High-purity: No contamination activity has been detected in standard test reactions.
Description
Taq DNA Polymerase is a thermostable DNA Polymerase isolated from an E. coli strain that carries the Taq DNA polymerase gene. Taq DNA Polymerase is the most common polymerase used for PCR*.Applications
The applications of Taq DNA Polymerase include the following:- PCR*
- 3'A-tailing of blunt ends
- Primer extension
- DNA sequencing
Formulation
GenScript Taq DNA Polymerase has been formulated using GenScript's proprietary technology. The enzyme can be shipped at room temperature or even 37°C for seven days without any loss of activity.QC Tests
PCR* performance, activity, nuclease|
|
|
Unit Definition
One unit is defined as the amount of enzyme that can incorporates 10 nmol of dNTP into acid-insoluble material in 30 minutes at 74°C.10 X Reaction Buffer (with Mg2+)
500 mM KCl, 100 mM Tris HCl (pH 9.0 at 25°C), 15 mM MgCl2, 1% Triton X-100Buffer. This buffer is optimized for use with 200 µM dNTPs.
Note: If the reaction is performed without this buffer, then add 0.1% Triton X-100 (final concentration) to ensure high activity.
Concentration:
Taq is delivered in 5 units/µl in 20 mM Tris HCl (pH 8.0), 0.1 mM EDTA, 1 mM DTT, 0.1% Triton X-100 and 50% glycerol.Storage
Store the product at -20°C.* The PCR process is covered by US. Patents Nos. 4683195 and 4683202, issued to Cetus and owned by Hoffman-La Roche Inc. GenScript does not encourage or support the unauthorized use of the PCR process. Use of this product is recommended for persons who either have a license to perform PCR or are not required to obtain a license. Sale of this product is restricted to regions or countries where native Taq DNA polymerase patents have been invalidated.
DATASHEET: 20060806230259 (PDF)
MSDS: 20060807040514 (PDF)
PROTOCOL: 20061215120639 (PDF)
COA: E00007_R201905 (PDF)
COA: E00007_R206904 (PDF)
COA: E00007_R204907 (PDF)
COA: E00007_R217906 (PDF)
COA: E00007_R219906 (PDF)
COA: E00007_R206910 (PDF)
COA: E00007_R207909 (PDF)
COA: E00007_R20011002 (PDF)
COA: E00007_R20031003 (PDF)
COA: E00007_R60011007 (PDF)
COA: E00007_R60011010 (PDF)
COA: E00007_R60011101 (PDF)
COA: E00007_R60071104 (PDF)
COA: E00007_C20031110 (PDF)
COA: E00007_C20011109 (PDF)
Publications used this GenScript Product:
- Gartner W, Vila G, Daneva T, Nabokikh A, Koc-Saral F, Ilhan A, Majdic O, Luger A, Wagner L. New functional aspects of the neuroendocrine marker secretagogin based on the characterization of its rat homologue. Am J Physiol Endocrinol Metab. Apr 2007; 293: E347-E354
- Abajy MY, Kopec J, Schiwon K, Burzynski M, Doring M, Bohn C, Grohmann E. A Type IV-Secretion-Like System (T4SLS) is Required for Conjugative DNA Transport of Plasmid pIP501 with Broad Host Range in Gram-Positive Bacteria. J. Bacteriol. Jan 2007; 189(6): 2487-2496
- Zeyu Xin, Yihong Zhao, and Zhi-Liang Zheng. Transcriptome Analysis Reveals Specific Modulation of Abscisic Acid Signaling by ROP10 Small GTPase in Arabidopsis. Plant Physiol. Oct 2005; 139(3): 1350-1365
- Gerard Crudden, Rachel E. Chitti, and Rolf J Craven. Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs. J. Pharmacol. Exp. Ther. Oct 2005; 316(1): 448-455
- Julia C Mallory, Gerard Crudden, Amelia Oliva, Christopher Saunders, Arnold Stromberg, Rolf J Craven. A novel group of genes regulate susceptibility to anti-neoplastic drugs in highly tumorigenic breast cancer cells. Mol. Pharmacol. Sep 2005; 68(6): 1747-1756
![]() |
|
1 |
Gene Synthesis: GenScript's custom gene synthesis service starts as LOW as $0.39/bp, with advanced FREE codon optimization tool and seamless cloning technology. |
2 |
PCR Cloning and Subcloning: Start GenScript's flexible PCR cloning and subcloning service RIGHT NOW, getting comprehensive packages delivered in 14 business days. |
3 |
Site-directed Mutagenesis Services: $149/mutation for special mutagenesis bundle. Site-directed Mutagenesis offers point mutations, deletions, and insertions with unparalleled accuracy, unlimited sites, and comprehensive service package. |
4 |
Plasmid DNA Preparation: GenScript plasmid DNA preparation services offer endotoxin FREE and predominantly supercoiling plasmid DNA from 100 ug to 1000 mg start from $50. |








